Novavax COVID shot, aimed at vaccine skeptics, overwhelmingly backed by FDA panel - BusinessWorld Online

  • 📰 bworldph
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 68%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

ADVISERS to the U.S. Food and Drug Administration voted overwhelmingly to recommend that the agency authorize Novavax Inc’s COVID-19 vaccine for use in adults, which the drugmaker hopes can become the shot of choice among some American vaccine skeptics.

The panel of outside vaccine experts voted 21-0 with one abstention in favor of the vaccine for those 18 and older after discussing whether the shot’s benefits outweigh risks, including rare occurrences of heart inflammation that may be associated with the vaccine.

Novavax’s shot, which is already available in over 40 countries, is a more traditional type of vaccine employing technology that has been used for decades to combat diseases like influenza. “Anything we can do to get people more comfortable to be able to accept these potentially life-saving medical products is something that we feel we are compelled to do,” he added.

A Department of Health and Human Services spokesperson noted that supply is likely to be limited in the near term.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Novavax will be the 'shot of choice' for everyone who wants a vaccine that works. It's the best vaccine, by every measure - efficacy, safety, transportation, storage, cost.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 9. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.